- Victim Assistance
- Consumer Protection
- Media Center
- Topical Index
MADISON — Attorney General J.B. Van Hollen today announced that he and 44 other Attorneys General have reached a $105 million settlement with GlaxoSmithKline LLC to resolve allegations that GlaxoSmithKline violated consumer protection laws in its promotion of its asthma drug, Advair®, and antidepressant drugs, Paxil® and Wellbutrin®. The Complaint filed today alleges that GlaxoSmithKline violated state consumer protection laws by misrepresenting the uses and qualities of these drugs. Under the settlement, Wisconsin will receive $1,958,888.19.
The Proposed Consent Judgment, which was submitted today for the Court’s consideration, requires GlaxoSmithKline (GSK) to reform its marketing and promotional practices. Specifically, under that Consent Judgment, GSK shall not:
The Consent Judgment also requires GSK to continue its Patient First Program or a substantially equivalent program through March 1, 2019. The Patient First Program reduces financial incentives for sales representatives to engage in improper marketing. In addition, the Consent Judgment requires scientifically trained personnel to be ultimately responsible for developing and approving clinical responses to health care provider questions regarding a GSK product, and for the data in these responses to be presented in an unbiased and non-promotional manner.
Also participating in the settlement are Alabama, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, the District of Columbia, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Maine, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Montana, Nebraska, Nevada, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, and Wyoming.
The State was represented by Assistant Attorney General Phillip D. Ferris.
Copies of the Complaint and the Proposed Consent Judgment submitted to the Court for its consideration are available at the following links: